Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

BACKGROUND: In women of reproductive age, polycystic ovary syndrome (PCOS) constitutes the most frequent endocrine disorder. Women with PCOS are considered to typically belong to an age and sex group which is at lower risk for severe COVID-19. MAIN BODY: Emerging data link the risk of severe COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyrou, Ioannis, Karteris, Emmanouil, Robbins, Tim, Chatha, Kamaljit, Drenos, Fotios, Randeva, Harpal S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360476/
https://www.ncbi.nlm.nih.gov/pubmed/32664957
http://dx.doi.org/10.1186/s12916-020-01697-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360476/
https://www.ncbi.nlm.nih.gov/pubmed/32664957
http://dx.doi.org/10.1186/s12916-020-01697-5

Ejemplares similares